Global Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Analysis by Product Type (Raw Materials, API), Service (Bioanalytical Testing, Stability Testing), End-User (Pharma Companies) and By Region (North America, Europe, Asia Pacific, Middle East and Africa and Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 - 2027
Industry Trends
Global pharmaceutical analytical testing outsourcing in healthcare market was valued at US$ 4602.86 million in 2018 and is anticipated to reach US$ 9930.59 million by 2027, growing at an estimated CAGR of 8.9% over the forecast period. Analytical testing is a vital portion in every phase of drug advancement and manufacturing. Like numerous other pharmaceutical, manufacturing and controlling activities, analytical testing is also regularly outsourced. Analytical testing helps in enabling real-time quality control along with optimizing and monitoring processes, describing biosimilars and biologics, and increases efficiency. The major reason for companies sending the work to outsourcing companies is the presence of experienced experts and to get hold of expensive analytical testing equipment’s which are commonly not available in-house.
As more multifaceted and vivid drugs enter the pipeline, it becomes critical for organisations to ensure that proper reliable, accurate and robust analytical methods are adopted to ensure proper quality and safety and that also adheres to strict timeline. Along with product development, analytical advancement is an incessant refining process, wherein products and procedure information accumulated at each expansion phase can be exploited to enhance the analytical approaches. This continuous upgradation approach is reinforced by strict regulatory norms: analytical approaches need to be equipped, but not authenticated until it reaches a particular phase. Once the analytical procedures are legalised, the FDA provides permission to be included throughout the life cycle of the product.
Analytical testing service is generally considered as a long-term project. On the service sponsor’s side, they are focusing more towards considering contract-based organisations as a tactical companion rather than temporary service provider. Analytical testing services are in favour of organisations that can provide integrated services, which permits them to cut the number of middle men, assist in modernising, and improving efficiency. Thus, the pharmaceutical analytical testing outsourcing in healthcare market witnessed a lucrative growth in the recent past and is anticipated to continue the same trend over the forecast period.
Rapid development of new products is a major factor driving the Pharmaceutical Analytical Testing Outsourcing in Healthcare Market. The prime reason is the rising focus on customized needs and advancement in technology which in turn reduces the life cycle of a product, which further leads to the outsourcing of the testing procedures to ensure implementation of the process within a limited time frame. Moreover, the introduction of combination products, biosimilars amongst others has led to a further upsurge in demand for some explicit class of analytical pharmaceutical procedures. Pharmaceutical analytical testing outsourcing services in healthcare has become a preferred service for many pharmaceutical companies due to its optimum efficiency, ability to satisfy the therapeutic needs and to acquire the expert services from on-demand services.
Pharmaceutical outsourcing companies have been investing heavily in the analytical testing. It has resulted in the lucrative growth of the market. Especially, in the research and development sector for the development of new products. For e.g. – companies such as Great Point, who is providing assistance to healthcare companies has invested more than $1.0 billion in healthcare companies since 2003, with most of the investment ranging between $7.0 and $25.0 million. Intertek Group plc, who is one of the global leader in providing laboratory outsourcing services and solutions has a huge research facility backed by huge investment put forward. Price benefits associated with outsourcing pharmaceutical analytical testing services and approvals have further resulted in the increasing demand for pharmaceutical analytical testing outsourcing in healthcare market. The major factor that restrains the growth of the market is the huge cost incurred in the drug development and quality inconsistencies in the drug is further limiting the pharmaceutical analytical testing outsourcing in healthcare market growth.
Service Insights
On the basis of services, bioanalytical testing held the major share in the pharmaceutical analytical testing outsourcing in healthcare market owing to the increasing number of clinical trials for new products. Clinical trials are research studies done by healthcare or pharmaceutical related individuals which aimed at assessing the medical or behavioural intervention. Clinical trial generally includes four main phases, starting from phase 1 trial, followed by phase two trial, phase three trial and phase four trial. Phase 1 trial tests an experimental conduct on a trivial group of healthy people (20 to 80) to critic its security and side effects and to identify the correct dosage. Phase two studies generally include more target groups and give more emphasis to the effectiveness on the drug compared to the safety side followed in the phase 1 trial. Phase three is much more of a detailed information regarding the safety and effectiveness and includes study with different people and different drug doses. And the number of people involved in the experiment is very high compared to the both the previous phases. In this trial, most important requisites are the FDA Approvals. If the FDA approves that the trial results are positive, it will announce the drug as the experimental drug or device. A Phase IV trial for drugs or devices is usually undertaken after the FDA approval. A device or drug's effectiveness and safety are monitored in large amongst diverse populations. Sometimes, the side effects of a drug may not be shown until people started taking it over a longer period of time. Clinical trials normally incurred more amount of time. For process like bioanalytical testing, it provides huge information to clinical studies to make it more appropriate and relevant. The advent of bioanalysis act as a vital means during the procedure of drug discovery and advancement of the drug. Over the past few decades, an excess of assays has been constantly established for NCEs (The National Counselor Examination for Licensure and Certification) to assist in the different stages of introduction and development. Additionally, multiple analytical trials are accessible for prescription medicines and generic products. Bioanalytical data formed in discovery and pre-clinical programs act as a trivial information to early clinical programs. Plasma concentration-response data acquired from these plans can be compared with human genes to understand whether any fluctuation is there or not.
Regional Insights
North America held the major share in the pharmaceutical analytical testing outsourcing in healthcare market owing to the presence of numerous pharmaceutical analytical testing outsourcing companies present in the region. For e.g. – Eurofins is one of the established biopharmaceutical outsourcing services partner focused on providing insights on pharmaceutical, biotechnology, cosmetic clients and medical device. The Group revolves around a whole chain of drug development to an international network of laboratories and testing units within global reach, uniform QA systems and high-quality services. One of the major trends in the region is the introduction of impurity solutions which is used as a stand-alone service in response to current regulatory norms and policies that set standards for the quantity of elemental impurities in drugs. Moreover, the United States pharmacopeial conventions (USP’s) requirement for controlling elemental impurities providing analytical methods and validation criteria was introduced in January 2018 for better monitoring of the drugs. The major analytical tests include potency studies, stability studies, method development and validation, compendia testing, compatibility studies, container closure testing and surface wipe sampling test. Compared to other companies, outsourcing companies provides an edge towards faster analytical response, better reliability, data safety, partnership development and lower cost. There are two types of outsourcing generally followed by the company, tactical and strategic outsourcing. Tactical outsourcing is generally a short-term solution towards complex situations, when a lab is overwhelmed by large volume or slow output. Strategics consulting, on the other hand, involves a long-term partnership that consists of decreased overhead costs and the ability to advance projects of lower priority.
Global Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue & Forecast, (US$ Million), 2015 – 2027
Competitive Landscape
Some of the players operating in the Pharmaceutical Analytical Testing Outsourcing in Healthcare Market are Toxikon, Inc.; Intertek Group PLC; SGS SA, Boston Analytical, Pace Analytical Services, LLC, West Pharmaceutical Services, Inc., WuXi AppTec, Inc., Pharmaceutical Product Development, LLC and Charles River Laboratories International, Inc amongst others.
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market players are undertaking various strategic initiatives such as mergers, acquisitions, collaborations, and service portfolio as well as geographic expansion. For instance, in May 2019, Intertek announced the expansion of its pharmaceutical laboratory services in Melbourne, England. Moreover, in August 2019, Boston Analytical opened a new office in Cambridge, which provides analytical testing among other services, thereby expanding the reach of its services.
Global Pharmaceutical Analytical Testing Outsourcing in Healthcare Market:
- Product type
- Raw Materials
- API
- By Service
- Bioanalytical Testing
- Stability Testing
- By Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Benelux Union
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
Table
of Contents
1. Market
Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2017
1.2.2. Base
Year: 2018
1.2.3. Forecast
Years: 2019 – 2027
2. Key Target
Audiences
3. Research
Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations
and Insights from AMI’s Perspective**
5. Holistic
Overview of Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
6. Market
Synopsis: Pharmaceutical Analytical
Testing Outsourcing in Healthcare Market
7. Pharmaceutical
Analytical Testing Outsourcing in Healthcare Market Analysis: Qualitative
Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Pharmaceutical Analytical Testing Outsourcing in
Healthcare Market
7.6. Porter’s
Five Force Analysis
8. Global
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Analysis and
Forecasts, 2019 – 2027
8.1. Overview
8.1.1. Global
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn)
8.2. Global
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Product type
8.2.1. Raw
Materials
8.2.1.1. Definition
8.2.1.2. Market
Estimation and Penetration, 2015 – 2018
8.2.1.3. Market
Forecast, 2019 – 2027
8.2.1.4. Compound
Annual Growth Rate (CAGR)
8.2.1.5. Regional
Bifurcation
8.2.1.5.1. North
America
8.2.1.5.1.1. Market
Estimation, 2015 – 2018
8.2.1.5.1.2. Market
Forecast, 2019 – 2027
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 – 2018
8.2.1.5.2.2. Market
Forecast, 2019 – 2027
8.2.1.5.3. Asia
Pacific
8.2.1.5.3.1. Market
Estimation, 2015 – 2018
8.2.1.5.3.2. Market
Forecast, 2019 – 2027
8.2.1.5.4. Middle
East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 – 2018
8.2.1.5.4.2. Market
Forecast, 2019 – 2027
8.2.1.5.5. Latin
America
8.2.1.5.5.1. Market
Estimation, 2015 – 2018
8.2.1.5.5.2. Market
Forecast, 2019 – 2027
8.2.2. API
8.2.2.1. Definition
8.2.2.2. Market
Estimation and Penetration, 2015 – 2018
8.2.2.3. Market
Forecast, 2019 – 2027
8.2.2.4. Compound
Annual Growth Rate (CAGR)
8.2.2.5. Regional
Bifurcation
8.2.2.5.1. North
America
8.2.2.5.1.1. Market
Estimation, 2015 – 2018
8.2.2.5.1.2. Market
Forecast, 2019 – 2027
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 – 2018
8.2.2.5.2.2. Market
Forecast, 2019 – 2027
8.2.2.5.3. Asia
Pacific
8.2.2.5.3.1. Market
Estimation, 2015 – 2018
8.2.2.5.3.2. Market
Forecast, 2019 – 2027
8.2.2.5.4. Middle
East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 – 2018
8.2.2.5.4.2. Market
Forecast, 2019 – 2027
8.2.2.5.5. Latin
America
8.2.2.5.5.1. Market
Estimation, 2015 – 2018
8.2.2.5.5.2. Market
Forecast, 2019 – 2027
8.3. Key
Segment for Channeling Investments
8.3.1. By
Product type
9. Global
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Analysis and
Forecasts, 2019 – 2027
9.1. Overview
9.2. Global
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Service
9.2.1. Bioanalytical
Testing
9.2.1.1. Definition
9.2.1.2. Market
Estimation and Penetration, 2015 – 2018
9.2.1.3. Market
Forecast, 2019 – 2027
9.2.1.4. Compound
Annual Growth Rate (CAGR)
9.2.1.5. Regional
Bifurcation
9.2.1.5.1. North
America
9.2.1.5.1.1. Market
Estimation, 2015 – 2018
9.2.1.5.1.2. Market
Forecast, 2019 – 2027
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 – 2018
9.2.1.5.2.2. Market
Forecast, 2019 – 2027
9.2.1.5.3. Asia
Pacific
9.2.1.5.3.1. Market
Estimation, 2015 – 2018
9.2.1.5.3.2. Market
Forecast, 2019 – 2027
9.2.1.5.4. Middle
East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 – 2018
9.2.1.5.4.2. Market
Forecast, 2019 – 2027
9.2.1.5.5. Latin
America
9.2.1.5.5.1. Market
Estimation, 2015 – 2018
9.2.1.5.5.2. Market
Forecast, 2019 – 2027
9.2.2. Stability
Testing
9.2.2.1. Definition
9.2.2.2. Market
Estimation and Penetration, 2015 – 2018
9.2.2.3. Market
Forecast, 2019 – 2027
9.2.2.4. Compound
Annual Growth Rate (CAGR)
9.2.2.5. Regional
Bifurcation
9.2.2.5.1. North
America
9.2.2.5.1.1. Market
Estimation, 2015 – 2018
9.2.2.5.1.2. Market
Forecast, 2019 – 2027
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 – 2018
9.2.2.5.2.2. Market
Forecast, 2019 – 2027
9.2.2.5.3. Asia
Pacific
9.2.2.5.3.1. Market
Estimation, 2015 – 2018
9.2.2.5.3.2. Market
Forecast, 2019 – 2027
9.2.2.5.4. Middle
East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 – 2018
9.2.2.5.4.2. Market
Forecast, 2019 – 2027
9.2.2.5.5. Latin
America
9.2.2.5.5.1. Market
Estimation, 2015 – 2018
9.2.2.5.5.2. Market
Forecast, 2019 – 2027
9.3. Key
Segment for Channeling Investments
9.3.1. By
Service
10. North
America Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Analysis and Forecasts, 2019 - 2027
10.1. Overview
10.1.1. North
America Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Revenue (US$ Mn)
10.2. North
America Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Product type
10.2.1. Raw
Materials
10.2.2. API
10.3. North
America Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Service
10.3.1. Bioanalytical
Testing
10.3.2. Stability
Testing
10.4. North
America Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Country
10.4.1. U.S
10.4.1.1. U.S
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Product type
10.4.1.1.1. Raw
Materials
10.4.1.1.2. API
10.4.1.2. U.S
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Service
10.4.1.2.1. Bioanalytical
Testing
10.4.1.2.2. Stability
Testing
10.4.2. Canada
10.4.2.1. Canada
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Product type
10.4.2.1.1. Raw
Materials
10.4.2.1.2. API
10.4.2.2. Canada
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Service
10.4.2.2.1. Bioanalytical
Testing
10.4.2.2.2. Stability
Testing
10.4.3. Mexico
10.4.3.1. Mexico
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Product type
10.4.3.1.1. Raw
Materials
10.4.3.1.2. API
10.4.3.2. Mexico
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Service
10.4.3.2.1. Bioanalytical
Testing
10.4.3.2.2. Stability
Testing
10.4.4. Rest of
North America
10.4.4.1. Rest
of North America Pharmaceutical Analytical Testing Outsourcing in Healthcare
Market Revenue (US$ Mn) and Forecasts, By Product type
10.4.4.1.1. Raw
Materials
10.4.4.1.2. API
10.4.4.2. Rest
of North America Pharmaceutical Analytical Testing Outsourcing in Healthcare
Market Revenue (US$ Mn) and Forecasts, By Service
10.4.4.2.1. Bioanalytical
Testing
10.4.4.2.2. Stability
Testing
10.5. Key
Segment for Channeling Investments
10.5.1. By
Country
10.5.2. By
Product type
10.5.3. By
Service
11. Europe
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Analysis and
Forecasts, 2019 - 2027
11.1. Overview
11.1.1. Europe
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn)
11.2. Europe
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Product type
11.2.1. Raw
Materials
11.2.2. API
11.3. Europe
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Service
11.3.1. Bioanalytical
Testing
11.3.2. Stability
Testing
11.4. Europe
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Country
11.4.1. France
11.4.1.1. France
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Product type
11.4.1.1.1. Raw
Materials
11.4.1.1.2. API
11.4.1.2. France
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Service
11.4.1.2.1. Bioanalytical
Testing
11.4.1.2.2. Stability
Testing
11.4.2. The UK
11.4.2.1. The
UK Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue
(US$ Mn) and Forecasts, By Product type
11.4.2.1.1. Raw
Materials
11.4.2.1.2. API
11.4.2.2. The
UK Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue
(US$ Mn) and Forecasts, By Service
11.4.2.2.1. Bioanalytical
Testing
11.4.2.2.2. Stability
Testing
11.4.3. Spain
11.4.3.1. Spain
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Product type
11.4.3.1.1. Raw
Materials
11.4.3.1.2. API
11.4.3.2. Spain
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Service
11.4.3.2.1. Bioanalytical
Testing
11.4.3.2.2. Stability
Testing
11.4.4. Germany
11.4.4.1. Germany
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Product type
11.4.4.1.1. Raw
Materials
11.4.4.1.2. API
11.4.4.2. Germany
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Service
11.4.4.2.1. Bioanalytical
Testing
11.4.4.2.2. Stability
Testing
11.4.5. Italy
11.4.5.1. Italy
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Product type
11.4.5.1.1. Raw
Materials
11.4.5.1.2. API
11.4.5.2. Italy
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Service
11.4.5.2.1. Bioanalytical
Testing
11.4.5.2.2. Stability
Testing
11.4.6. Nordic
Countries
11.4.6.1. Nordic
Countries Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Product type
11.4.6.1.1. Raw
Materials
11.4.6.1.2. API
11.4.6.2. Nordic
Countries Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Service
11.4.6.2.1. Bioanalytical
Testing
11.4.6.2.2. Stability
Testing
11.4.6.3. Nordic
Countries Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Country
11.4.6.3.1. Denmark
11.4.6.3.2. Finland
11.4.6.3.3. Iceland
11.4.6.3.4. Sweden
11.4.6.3.5. Norway
11.4.7. Benelux
Union
11.4.7.1. Benelux
Union Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Product type
11.4.7.1.1. Raw
Materials
11.4.7.1.2. API
11.4.7.2. Benelux
Union Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Service
11.4.7.2.1. Bioanalytical
Testing
11.4.7.2.2. Stability
Testing
11.4.7.3. Benelux
Union Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Country
11.4.7.3.1. Belgium
11.4.7.3.2. The
Netherlands
11.4.7.3.3. Luxembourg
11.4.8. Rest of
Europe
11.4.8.1. Rest
of Europe Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Product type
11.4.8.1.1. Raw
Materials
11.4.8.1.2. API
11.4.8.2. Rest
of Europe Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Service
11.4.8.2.1. Bioanalytical
Testing
11.4.8.2.2. Stability
Testing
11.5. Key
Segment for Channeling Investments
11.5.1. By
Country
11.5.2. By
Product type
11.5.3. By Service
12. Asia
Pacific Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Analysis and Forecasts, 2019 - 2027
12.1. Overview
12.1.1. Asia
Pacific Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Revenue (US$ Mn)
12.2. Asia
Pacific Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Product type
12.2.1. Raw
Materials
12.2.2. API
12.3. Asia
Pacific Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Service
12.3.1. Bioanalytical
Testing
12.3.2. Stability
Testing
12.4. Asia
Pacific Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Country
12.4.1. China
12.4.1.1. China
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Product type
12.4.1.1.1. Raw
Materials
12.4.1.1.2. API
12.4.1.2. China
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Service
12.4.1.2.1. Bioanalytical
Testing
12.4.1.2.2. Stability
Testing
12.4.2. Japan
12.4.2.1. Japan
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Product type
12.4.2.1.1. Raw
Materials
12.4.2.1.2. API
12.4.2.2. Japan
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Service
12.4.2.2.1. Bioanalytical
Testing
12.4.2.2.2. Stability
Testing
12.4.3. India
12.4.3.1. India
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Product type
12.4.3.1.1. Raw
Materials
12.4.3.1.2. API
12.4.3.2. India
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Service
12.4.3.2.1. Bioanalytical
Testing
12.4.3.2.2. Stability
Testing
12.4.4. New
Zealand
12.4.4.1. New
Zealand Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Product type
12.4.4.1.1. Raw
Materials
12.4.4.1.2. API
12.4.4.2. New
Zealand Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Service
12.4.4.2.1. Bioanalytical
Testing
12.4.4.2.2. Stability
Testing
12.4.5. Australia
12.4.5.1. Australia
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Product type
12.4.5.1.1. Raw
Materials
12.4.5.1.2. API
12.4.5.2. Australia
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Service
12.4.5.2.1. Bioanalytical
Testing
12.4.5.2.2. Stability
Testing
12.4.6. South
Korea
12.4.6.1. South
Korea Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue
(US$ Mn) and Forecasts, By Product type
12.4.6.1.1. Raw
Materials
12.4.6.1.2. API
12.4.6.2. South
Korea Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Service
12.4.6.2.1. Bioanalytical
Testing
12.4.6.2.2. Stability
Testing
12.4.7. Southeast
Asia
12.4.7.1. Southeast
Asia Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue
(US$ Mn) and Forecasts, By Product type
12.4.7.1.1. Raw
Materials
12.4.7.1.2. API
12.4.7.2. Southeast
Asia Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue
(US$ Mn) and Forecasts, By Service
12.4.7.2.1. Bioanalytical
Testing
12.4.7.2.2. Stability
Testing
12.4.7.3. Southeast
Asia Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue
(US$ Mn) and Forecasts, By Country
12.4.7.3.1. Indonesia
12.4.7.3.2. Thailand
12.4.7.3.3. Malaysia
12.4.7.3.4. Singapore
12.4.7.3.5. Rest
of Southeast Asia
12.4.8. Rest of
Asia Pacific
12.4.8.1. Rest
of Asia Pacific Pharmaceutical Analytical Testing Outsourcing in Healthcare
Market Revenue (US$ Mn) and Forecasts, By Product type
12.4.8.1.1. Raw
Materials
12.4.8.1.2. API
12.4.8.2. Rest
of Asia Pacific Pharmaceutical Analytical Testing Outsourcing in Healthcare
Market Revenue (US$ Mn) and Forecasts, By Service
12.4.8.2.1. Bioanalytical
Testing
12.4.8.2.2. Stability
Testing
12.5. Key
Segment for Channeling Investments
12.5.1. By
Country
12.5.2. By
Product type
12.5.3. By
Service
13. Middle East
and Africa Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Analysis and Forecasts, 2019 - 2027
13.1. Overview
13.1.1. Middle
East and Africa Pharmaceutical Analytical Testing Outsourcing in Healthcare
Market Revenue (US$ Mn)
13.2. Middle
East and Africa Pharmaceutical Analytical Testing Outsourcing in Healthcare
Market Revenue (US$ Mn) and Forecasts, By Product type
13.2.1. Raw
Materials
13.2.2. API
13.3. Middle
East and Africa Pharmaceutical Analytical Testing Outsourcing in Healthcare
Market Revenue (US$ Mn) and Forecasts, By Service
13.3.1. Bioanalytical
Testing
13.3.2. Stability
Testing
13.4. Middle
East and Africa Pharmaceutical Analytical Testing Outsourcing in Healthcare
Market Revenue (US$ Mn) and Forecasts, By Country
13.4.1. Saudi
Arabia
13.4.1.1. Saudi
Arabia Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Product type
13.4.1.1.1. Raw
Materials
13.4.1.1.2. API
13.4.1.2. Saudi
Arabia Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Service
13.4.1.2.1. Bioanalytical
Testing
13.4.1.2.2. Stability
Testing
13.4.2. UAE
13.4.2.1. UAE
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Product type
13.4.2.1.1. Raw
Materials
13.4.2.1.2. API
13.4.2.2. UAE
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Service
13.4.2.2.1. Bioanalytical
Testing
13.4.2.2.2. Stability
Testing
13.4.3. Egypt
13.4.3.1. Egypt
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Product type
13.4.3.1.1. Raw
Materials
13.4.3.1.2. API
13.4.3.2. Egypt
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Service
13.4.3.2.1. Bioanalytical
Testing
13.4.3.2.2. Stability
Testing
13.4.4. Kuwait
13.4.4.1. Kuwait
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Product type
13.4.4.1.1. Raw
Materials
13.4.4.1.2. API
13.4.4.2. Kuwait
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Service
13.4.4.2.1. Bioanalytical
Testing
13.4.4.2.2. Stability
Testing
13.4.5. South
Africa
13.4.5.1. South
Africa Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Product type
13.4.5.1.1. Raw
Materials
13.4.5.1.2. API
13.4.5.2. South
Africa Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Service
13.4.5.2.1. Bioanalytical
Testing
13.4.5.2.2. Stability
Testing
13.4.6. Rest of
Middle East & Africa
13.4.6.1. Rest
of Middle East & Africa Pharmaceutical Analytical Testing Outsourcing in
Healthcare Market Revenue (US$ Mn) and Forecasts, By Product type
13.4.6.1.1. Raw
Materials
13.4.6.1.2. API
13.4.6.2. Rest
of Middle East & Africa Pharmaceutical Analytical Testing Outsourcing in
Healthcare Market Revenue (US$ Mn) and Forecasts, By Service
13.4.6.2.1. Bioanalytical
Testing
13.4.6.2.2. Stability
Testing
13.5. Key
Segment for Channeling Investments
13.5.1. By
Country
13.5.2. By
Product type
13.5.3. By
Service
14. Latin
America Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Analysis and Forecasts, 2019 - 2027
14.1. Overview
14.1.1. Latin
America Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Revenue (US$ Mn)
14.2. Latin
America Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Product type
14.2.1. Raw
Materials
14.2.2. API
14.3. Latin
America Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Service
14.3.1. Bioanalytical
Testing
14.3.2. Stability
Testing
14.4. Latin
America Pharmaceutical Analytical Testing Outsourcing in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Country
14.4.1. Brazil
14.4.1.1. Brazil
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Product type
14.4.1.1.1. Raw
Materials
14.4.1.1.2. API
14.4.1.2. Brazil
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Service
14.4.1.2.1. Bioanalytical
Testing
14.4.1.2.2. Stability
Testing
14.4.2. Argentina
14.4.2.1. Argentina
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Product type
14.4.2.1.1. Raw
Materials
14.4.2.1.2. API
14.4.2.2. Argentina
Pharmaceutical Analytical Testing Outsourcing in Healthcare Market Revenue (US$
Mn) and Forecasts, By Service
14.4.2.2.1. Bioanalytical
Testing
14.4.2.2.2. Stability
Testing
14.4.3. Rest of
Latin America
14.4.3.1. Rest
of Latin America Pharmaceutical Analytical Testing Outsourcing in Healthcare
Market Revenue (US$ Mn) and Forecasts, By Product type
14.4.3.1.1. Raw
Materials
14.4.3.1.2. API
14.4.3.2. Rest
of Latin America Pharmaceutical Analytical Testing Outsourcing in Healthcare
Market Revenue (US$ Mn) and Forecasts, By Service
14.4.3.2.1. Bioanalytical
Testing
14.4.3.2.2. Stability
Testing
14.5. Key
Segment for Channeling Investments
14.5.1. By
Country
14.5.2. By
Product type
14.5.3. By
Service
15. Competitive
Benchmarking
15.1. Market
Share Analysis, 2018
15.2. Global
Presence and Growth Strategies
15.2.1. Mergers
and Acquisitions
15.2.2. Product
Launches
15.2.3. Investments
Trends
15.2.4. R&D
Initiatives
16. Player
Profiles
16.1. Boston
Analytical
16.1.1. Company
Details
16.1.2. Company
Overview
16.1.3. Product
Offerings
16.1.4. Key
Developments
16.1.5. Financial
Analysis
16.1.6. SWOT
Analysis
16.1.7. Business
Strategies
16.2. Charles
River Laboratories International, Inc.
16.2.1. Company
Details
16.2.2. Company
Overview
16.2.3. Product
Offerings
16.2.4. Key
Developments
16.2.5. Financial
Analysis
16.2.6. SWOT
Analysis
16.2.7. Business
Strategies
16.3. Eurofins
Scientific
16.3.1. Company
Details
16.3.2. Company
Overview
16.3.3. Product
Offerings
16.3.4. Key
Developments
16.3.5. Financial
Analysis
16.3.6. SWOT
Analysis
16.3.7. Business
Strategies
16.4. Intertek
Group PLC
16.4.1. Company
Details
16.4.2. Company
Overview
16.4.3. Product
Offerings
16.4.4. Key
Developments
16.4.5. Financial
Analysis
16.4.6. SWOT
Analysis
16.4.7. Business
Strategies
16.5. Pace
Analytical Services, LLCs
16.5.1. Company
Details
16.5.2. Company
Overview
16.5.3. Product
Offerings
16.5.4. Key Developments
16.5.5. Financial
Analysis
16.5.6. SWOT
Analysis
16.5.7. Business
Strategies
16.6. Pharmaceutical
Product Development, LLC
16.6.1. Company
Details
16.6.2. Company
Overview
16.6.3. Product
Offerings
16.6.4. Key
Developments
16.6.5. Financial
Analysis
16.6.6. SWOT
Analysis
16.6.7. Business
Strategies
16.7. SGS SA
16.7.1. Company
Details
16.7.2. Company
Overview
16.7.3. Product
Offerings
16.7.4. Key
Developments
16.7.5. Financial
Analysis
16.7.6. SWOT
Analysis
16.7.7. Business
Strategies
16.8. Toxikon,
Inc
16.8.1. Company
Details
16.8.2. Company
Overview
16.8.3. Product
Offerings
16.8.4. Key
Developments
16.8.5. Financial
Analysis
16.8.6. SWOT
Analysis
16.8.7. Business
Strategies
16.9. West
Pharmaceutical Services, Inc
16.9.1. Company
Details
16.9.2. Company
Overview
16.9.3. Product
Offerings
16.9.4. Key
Developments
16.9.5. Financial
Analysis
16.9.6. SWOT
Analysis
16.9.7. Business
Strategies
16.10. WuXi
AppTec, Inc
16.10.1. Company
Details
16.10.2. Company
Overview
16.10.3. Product
Offerings
16.10.4. Key
Developments
16.10.5. Financial
Analysis
16.10.6. SWOT
Analysis
16.10.7. Business
Strategies
16.11. Other
market participants
Key FindingsNote: This ToC is tentative and can be changed according to
the research study conducted during the course of report completion.
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com


Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.
